Table 2 Characteristics of Children and Adolescents with Endemic KS in Context of a Pediatric-Specific Staging Classification
Stage 1: Mild/Moderate Cutaneous/Oral KS | Stage 2: Lymphadenopathic KS | Stage 3: Woody Edema KS | Stage 4: Visceral and/or Disseminated Cutaneous/Oral KS | |
|---|---|---|---|---|
Number of patients, n | 4 | 6 | 6 | 4 |
Baseline Anemia (hgb < 8), n (%) | 0 | 5 (83%) | 1 (17%) | 3 (75%) |
Baseline Thrombocytopenia (platelet count < 100), n (%) | 1 (25%) | 4 (67%) | 0 | 3 (75%) |
Alive in complete remission, n (%) | 3 (75%) | 5 (83%) | 1 (17%) | 0 |
Alive with stable disease, n (%) | 0 | 0 | 3 (50%) | 1 (25%) |
Deaths, n (%) | 1 (25%) | 1 (17%) | 2 (33%) | 3 (75%) |
KS related death | 0 | 1 | 2 | 3 |
Non-KS related death | 1 | 0 | 0 | 0 |
2-year EFS in HIV+ KS cohorta | too few patients to determine | 73% | 29% | 0 |
2-year OS in HIV+ KS cohorta | 75% | 79% | 12% |